Mounjaro, the widely prescribed type 2 diabetes medication, has received a significant new approval from the Food and Drug Administration. The agency has cleared the drug to reduce the risk of heart attack, stroke and cardiovascular death in adults with type 2 diabetes who are already at elevated risk for those events, according to an […]

The postFDA approves Mounjaro for a bigger heart risk fightappeared first onRolling Out.